🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to complete the total safety database size for...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-07-19
Trial ID
NCT03954743
This study is a randomized, double-blinded, and placebo-controlled phase Ia...
Status
Completed
Location
West China Second University Hospital, Sichuan University / West China women's and children's Hospital
Start Date
2020-05-15
Trial ID
NCT04412538
Treatments Being Tested
To evaluate the immunogenicity and safety of the third dose SARS-CoV-2 Vacc...
Status
Unknown
Location
Anning First People's Hospital
Start Date
2021-12-18
Trial ID
NCT05163652
Treatments Being Tested
Reported in the 2018 NEJM (378; 1277) article, the combination of checkpoin...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-08-31
Trial ID
NCT03598816
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, reactogenicity...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-02-20
Trial ID
NCT02141204
Treatments Being Tested
This study will collect information on the safety of BNT162b2 products for ...
Status
Active Not Recruiting
Location
Pfizer
Start Date
2022-03-18
Trial ID
NCT05032976
Treatments Being Tested
This study is a randomized, double-blinded, placebo-controlled phase 2 clin...
Status
Unknown
Location
Tongxu Center for Disease Prevention and Control
Start Date
2023-10-20
Trial ID
NCT06080906
The purpose of this study is to determine the safety and efficacy of a PEPI...
Status
Recruiting
Location
Duke University Medical Center
Start Date
2025-07-15
Trial ID
NCT05609994
Treatments Being Tested
The purpose of this study was to evaluate the reactogenicity, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-02-02
Trial ID
NCT05169905
Treatments Being Tested
TYPE / DESIGN STUDY: Clinical trial phase II / III, randomized, double-blin...
Status
Unknown
Location
• Unidade de Ensaios Clínicos para Imunobiológicos/Instituto de Tecnologia em Imunobiológicos de Bio-Manguinhos/Fiocruz
Start Date
2018-09-25
Trial ID
NCT02858570
Treatments Being Tested